A Study of AT-02 in Subjects With Systemic Amyloidosis.

Clinical trial NCT05951049 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05951049
Sponsor: Attralus, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyloidosis; Systemic

Start date: 2023-09-21
Primary completion: 2026-09-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.